0.018129
0.000000
0.000000
0.000000
0.018868
0.000000
0.000000
0.000000
0.012151
0.00000
0.00000
0.00000
Nienaber, V.
http://mmcif.pdb.org/dictionaries/ascii/mmcif_pdbx.dic
4
90.00
90.00
90.00
55.160
53.000
82.300
C7 H7 N3 O
149.150
2-AMINO-5-HYDROXY-BENZIMIDAZOLE
non-polymer
C3 H7 N O2
89.093
y
ALANINE
L-peptide linking
C6 H15 N4 O2 1
175.209
y
ARGININE
L-peptide linking
C4 H8 N2 O3
132.118
y
ASPARAGINE
L-peptide linking
C4 H7 N O4
133.103
y
ASPARTIC ACID
L-peptide linking
C3 H7 N O2 S
121.158
y
CYSTEINE
L-peptide linking
C5 H10 N2 O3
146.144
y
GLUTAMINE
L-peptide linking
C5 H9 N O4
147.129
y
GLUTAMIC ACID
L-peptide linking
C2 H5 N O2
75.067
y
GLYCINE
peptide linking
C6 H10 N3 O2 1
156.162
y
HISTIDINE
L-peptide linking
C6 H13 N O2
131.173
y
ISOLEUCINE
L-peptide linking
C6 H13 N O2
131.173
y
LEUCINE
L-peptide linking
C6 H15 N2 O2 1
147.195
y
LYSINE
L-peptide linking
C5 H11 N O2 S
149.211
y
METHIONINE
L-peptide linking
C9 H11 N O2
165.189
y
PHENYLALANINE
L-peptide linking
C5 H9 N O2
115.130
y
PROLINE
L-peptide linking
C3 H7 N O3
105.093
y
SERINE
L-peptide linking
O4 S -2
96.063
SULFATE ION
non-polymer
C4 H9 N O3
119.119
y
THREONINE
L-peptide linking
C11 H12 N2 O2
204.225
y
TRYPTOPHAN
L-peptide linking
C9 H11 N O3
181.189
y
TYROSINE
L-peptide linking
C5 H11 N O2
117.146
y
VALINE
L-peptide linking
US
J.Med.Chem.
JMCMAR
0151
0022-2623
43
3862
3866
10.1021/jm0002228
11052791
Identification of novel inhibitors of urokinase via NMR-based screening.
2000
US
J.Biol.Chem.
JBCHA3
0071
0021-9258
275
7239
7248
Re-engineering of human urokinase provides a system for structure-based drug design at high resolution and reveals a novel structural subsite
2000
1.000000
0.000000
0.000000
0.000000
1.000000
0.000000
0.000000
0.000000
1.000000
0.00000
0.00000
0.00000
160
1
IMAGE PLATE
RIGAKU RAXIS II
SINGLE WAVELENGTH
M
x-ray
1
1.54
1.0
1.54
ROTATING ANODE
RIGAKU
27590.430
UROKINASE
3.4.21.73
B CHAIN (16-243)
C122A, N145Q
1
man
polymer
96.063
SULFATE ION
1
syn
non-polymer
149.150
2-AMINO-5-HYDROXY-BENZIMIDAZOLE
1
syn
non-polymer
no
no
IIGGEFTTIENQPWFAAIYRRHRGGSVTYVCGGSLMSPCWVISATHCFIDYPKKEDYIVYLGRSRLNSNTQGEMKFEVEN
LILHKDYSADTLAHHNDIALLKIRSKEGRCAQPSRTIQTIALPSMYNDPQFGTSCEITGFGKENSTDYLYPEQLKMTVVK
LISHRECQQPHYYGSEVTTKMLCAADPQWKTDSCQGDSGGPLVCSLQGRMTLTGIVSWGRGCALKDKPGVYTRVSHFLPW
IRSHT
IIGGEFTTIENQPWFAAIYRRHRGGSVTYVCGGSLMSPCWVISATHCFIDYPKKEDYIVYLGRSRLNSNTQGEMKFEVEN
LILHKDYSADTLAHHNDIALLKIRSKEGRCAQPSRTIQTIALPSMYNDPQFGTSCEITGFGKENSTDYLYPEQLKMTVVK
LISHRECQQPHYYGSEVTTKMLCAADPQWKTDSCQGDSGGPLVCSLQGRMTLTGIVSWGRGCALKDKPGVYTRVSHFLPW
IRSHT
A
polypeptide(L)
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
n
human
Homo
fall armyworm
Spodoptera
sample
9606
Homo sapiens
7108
Spodoptera frugiperda
BACULOVIRUS
1
2.18
43.58
VAPOR DIFFUSION, HANGING DROP
0.15M LiSo4, 20% PEG 4000, succinate buffer, VAPOR DIFFUSION, HANGING DROP, temperature 18K
291.0
software
exptl_crystal_grow
repository
Initial release
Version format compliance
Version format compliance
Refinement description
Experimental preparation
1
0
2000-10-18
1
1
2008-04-27
1
2
2011-07-13
1
3
2017-10-04
1
4
2018-01-31
_exptl_crystal_grow.temp
RCSB
Y
RCSB
2000-09-19
REL
SO4
SULFATE ION
172
2-AMINO-5-HYDROXY-BENZIMIDAZOLE
SO4
1
2
SO4
SO4
245
A
172
1
3
172
172
246
A
ILE
1
n
1
ILE
1
A
ILE
2
n
2
ILE
2
A
GLY
3
n
3
GLY
3
A
GLY
4
n
4
GLY
4
A
GLU
5
n
5
GLU
5
A
PHE
6
n
6
PHE
6
A
THR
7
n
7
THR
7
A
THR
8
n
8
THR
8
A
ILE
9
n
9
ILE
9
A
GLU
10
n
10
GLU
10
A
ASN
11
n
11
ASN
11
A
GLN
12
n
12
GLN
12
A
PRO
13
n
13
PRO
13
A
TRP
14
n
14
TRP
14
A
PHE
15
n
15
PHE
15
A
ALA
16
n
16
ALA
16
A
ALA
17
n
17
ALA
17
A
ILE
18
n
18
ILE
18
A
TYR
19
n
19
TYR
19
A
ARG
20
n
20
ARG
20
A
ARG
21
n
21
ARG
21
A
HIS
22
n
22
HIS
22
A
ARG
23
n
23
ARG
23
A
GLY
23
n
24
A
GLY
23
A
GLY
24
n
25
GLY
24
A
SER
25
n
26
SER
25
A
VAL
26
n
27
VAL
26
A
THR
27
n
28
THR
27
A
TYR
28
n
29
TYR
28
A
VAL
29
n
30
VAL
29
A
CYS
30
n
31
CYS
30
A
GLY
31
n
32
GLY
31
A
GLY
32
n
33
GLY
32
A
SER
33
n
34
SER
33
A
LEU
34
n
35
LEU
34
A
MET
35
n
36
MET
35
A
SER
36
n
37
SER
36
A
PRO
37
n
38
PRO
37
A
CYS
38
n
39
CYS
38
A
TRP
39
n
40
TRP
39
A
VAL
40
n
41
VAL
40
A
ILE
41
n
42
ILE
41
A
SER
42
n
43
SER
42
A
ALA
43
n
44
ALA
43
A
THR
44
n
45
THR
44
A
HIS
45
n
46
HIS
45
A
CYS
46
n
47
CYS
46
A
PHE
47
n
48
PHE
47
A
ILE
48
n
49
ILE
48
A
ASP
49
n
50
ASP
49
A
TYR
50
n
51
TYR
50
A
PRO
51
n
52
PRO
51
A
LYS
52
n
53
LYS
52
A
LYS
53
n
54
LYS
53
A
GLU
54
n
55
GLU
54
A
ASP
55
n
56
ASP
55
A
TYR
56
n
57
TYR
56
A
ILE
57
n
58
ILE
57
A
VAL
58
n
59
VAL
58
A
TYR
59
n
60
TYR
59
A
LEU
60
n
61
LEU
60
A
GLY
61
n
62
GLY
61
A
ARG
62
n
63
ARG
62
A
SER
63
n
64
SER
63
A
ARG
64
n
65
ARG
64
A
LEU
65
n
66
LEU
65
A
ASN
66
n
67
ASN
66
A
SER
67
n
68
SER
67
A
ASN
68
n
69
ASN
68
A
THR
69
n
70
THR
69
A
GLN
70
n
71
GLN
70
A
GLY
71
n
72
GLY
71
A
GLU
72
n
73
GLU
72
A
MET
73
n
74
MET
73
A
LYS
74
n
75
LYS
74
A
PHE
75
n
76
PHE
75
A
GLU
76
n
77
GLU
76
A
VAL
77
n
78
VAL
77
A
GLU
78
n
79
GLU
78
A
ASN
79
n
80
ASN
79
A
LEU
80
n
81
LEU
80
A
ILE
81
n
82
ILE
81
A
LEU
82
n
83
LEU
82
A
HIS
83
n
84
HIS
83
A
LYS
84
n
85
LYS
84
A
ASP
85
n
86
ASP
85
A
TYR
86
n
87
TYR
86
A
SER
87
n
88
SER
87
A
ALA
88
n
89
ALA
88
A
ASP
89
n
90
ASP
89
A
THR
90
n
91
THR
90
A
LEU
91
n
92
LEU
91
A
ALA
92
n
93
ALA
92
A
HIS
93
n
94
HIS
93
A
HIS
94
n
95
HIS
94
A
ASN
95
n
96
ASN
95
A
ASP
96
n
97
ASP
96
A
ILE
97
n
98
ILE
97
A
ALA
98
n
99
ALA
98
A
LEU
99
n
100
LEU
99
A
LEU
100
n
101
LEU
100
A
LYS
101
n
102
LYS
101
A
ILE
102
n
103
ILE
102
A
ARG
103
n
104
ARG
103
A
SER
104
n
105
SER
104
A
LYS
105
n
106
LYS
105
A
GLU
106
n
107
GLU
106
A
GLY
107
n
108
GLY
107
A
ARG
108
n
109
ARG
108
A
CYS
109
n
110
CYS
109
A
ALA
110
n
111
ALA
110
A
GLN
111
n
112
GLN
111
A
PRO
112
n
113
PRO
112
A
SER
113
n
114
SER
113
A
ARG
114
n
115
ARG
114
A
THR
115
n
116
THR
115
A
ILE
116
n
117
ILE
116
A
GLN
117
n
118
GLN
117
A
THR
118
n
119
THR
118
A
ILE
119
n
120
ILE
119
A
ALA
120
n
121
ALA
120
A
LEU
121
n
122
LEU
121
A
PRO
122
n
123
PRO
122
A
SER
123
n
124
SER
123
A
MET
124
n
125
MET
124
A
TYR
125
n
126
TYR
125
A
ASN
126
n
127
ASN
126
A
ASP
127
n
128
ASP
127
A
PRO
128
n
129
PRO
128
A
GLN
129
n
130
GLN
129
A
PHE
130
n
131
PHE
130
A
GLY
131
n
132
GLY
131
A
THR
132
n
133
THR
132
A
SER
133
n
134
SER
133
A
CYS
134
n
135
CYS
134
A
GLU
135
n
136
GLU
135
A
ILE
136
n
137
ILE
136
A
THR
137
n
138
THR
137
A
GLY
138
n
139
GLY
138
A
PHE
139
n
140
PHE
139
A
GLY
140
n
141
GLY
140
A
LYS
141
n
142
LYS
141
A
GLU
142
n
143
GLU
142
A
ASN
143
n
144
ASN
143
A
SER
144
n
145
SER
144
A
THR
145
n
146
THR
145
A
ASP
146
n
147
ASP
146
A
TYR
147
n
148
TYR
147
A
LEU
148
n
149
LEU
148
A
TYR
149
n
150
TYR
149
A
PRO
150
n
151
PRO
150
A
GLU
151
n
152
GLU
151
A
GLN
152
n
153
GLN
152
A
LEU
153
n
154
LEU
153
A
LYS
154
n
155
LYS
154
A
MET
155
n
156
MET
155
A
THR
156
n
157
THR
156
A
VAL
157
n
158
VAL
157
A
VAL
158
n
159
VAL
158
A
LYS
159
n
160
LYS
159
A
LEU
160
n
161
LEU
160
A
ILE
161
n
162
ILE
161
A
SER
162
n
163
SER
162
A
HIS
163
n
164
HIS
163
A
ARG
164
n
165
ARG
164
A
GLU
165
n
166
GLU
165
A
CYS
166
n
167
CYS
166
A
GLN
167
n
168
GLN
167
A
GLN
168
n
169
GLN
168
A
PRO
169
n
170
PRO
169
A
HIS
170
n
171
HIS
170
A
TYR
171
n
172
TYR
171
A
TYR
172
n
173
TYR
172
A
GLY
173
n
174
GLY
173
A
SER
174
n
175
SER
174
A
GLU
175
n
176
GLU
175
A
VAL
176
n
177
VAL
176
A
THR
177
n
178
THR
177
A
THR
178
n
179
THR
178
A
LYS
179
n
180
LYS
179
A
MET
180
n
181
MET
180
A
LEU
181
n
182
LEU
181
A
CYS
182
n
183
CYS
182
A
ALA
183
n
184
ALA
183
A
ALA
184
n
185
ALA
184
A
ASP
185
n
186
ASP
185
A
PRO
186
n
187
PRO
186
A
GLN
187
n
188
GLN
187
A
TRP
188
n
189
TRP
188
A
LYS
189
n
190
LYS
189
A
THR
190
n
191
THR
190
A
ASP
191
n
192
ASP
191
A
SER
192
n
193
SER
192
A
CYS
193
n
194
CYS
193
A
GLN
194
n
195
GLN
194
A
GLY
195
n
196
GLY
195
A
ASP
196
n
197
ASP
196
A
SER
197
n
198
SER
197
A
GLY
198
n
199
GLY
198
A
GLY
199
n
200
GLY
199
A
PRO
200
n
201
PRO
200
A
LEU
201
n
202
LEU
201
A
VAL
202
n
203
VAL
202
A
CYS
203
n
204
CYS
203
A
SER
204
n
205
SER
204
A
LEU
205
n
206
LEU
205
A
GLN
206
n
207
GLN
206
A
GLY
207
n
208
GLY
207
A
ARG
208
n
209
ARG
208
A
MET
209
n
210
MET
209
A
THR
210
n
211
THR
210
A
LEU
211
n
212
LEU
211
A
THR
212
n
213
THR
212
A
GLY
213
n
214
GLY
213
A
ILE
214
n
215
ILE
214
A
VAL
215
n
216
VAL
215
A
SER
216
n
217
SER
216
A
TRP
217
n
218
TRP
217
A
GLY
218
n
219
GLY
218
A
ARG
219
n
220
ARG
219
A
GLY
220
n
221
GLY
220
A
CYS
221
n
222
CYS
221
A
ALA
222
n
223
ALA
222
A
LEU
223
n
224
LEU
223
A
LYS
224
n
225
LYS
224
A
ASP
225
n
226
ASP
225
A
LYS
226
n
227
LYS
226
A
PRO
227
n
228
PRO
227
A
GLY
228
n
229
GLY
228
A
VAL
229
n
230
VAL
229
A
TYR
230
n
231
TYR
230
A
THR
231
n
232
THR
231
A
ARG
232
n
233
ARG
232
A
VAL
233
n
234
VAL
233
A
SER
234
n
235
SER
234
A
HIS
235
n
236
HIS
235
A
PHE
236
n
237
PHE
236
A
LEU
237
n
238
LEU
237
A
PRO
238
n
239
PRO
238
A
TRP
239
n
240
TRP
239
A
ILE
240
n
241
ILE
240
A
ARG
241
n
242
ARG
241
A
SER
242
n
243
SER
242
A
HIS
243
n
244
HIS
243
A
THR
244
n
245
THR
244
A
author_defined_assembly
1
monomeric
1.0000000000
0.0000000000
0.0000000000
0.0000000000
1.0000000000
0.0000000000
0.0000000000
0.0000000000
1.0000000000
1_555
x,y,z
identity operation
0.0000000000
0.0000000000
0.0000000000
A
O
GLU
5
A
O
GLU
5
A
N
MET
155
A
N
MET
156
A
O
VAL
158
A
O
VAL
159
A
N
CYS
134
A
N
CYS
135
A
O
CYS
30
A
O
CYS
31
A
N
ILE
18
A
N
ILE
18
A
N
TYR
19
A
N
TYR
19
A
O
ILE
57
A
O
ILE
58
A
O
LEU
60
A
O
LEU
61
A
N
MET
73
A
N
MET
74
A
N
ILE
81
A
N
ILE
82
A
O
LEU
99
A
O
LEU
100
A
N
LEU
100
A
N
LEU
101
A
O
VAL
40
A
O
VAL
41
A
N
ILE
41
A
N
ILE
42
A
O
SER
33
A
O
SER
34
A
O
SER
87
A
O
SER
88
A
N
HIS
94
A
N
HIS
95
A
O
ALA
183
A
O
ALA
184
A
N
GLY
228
A
N
GLY
229
A
N
THR
231
A
N
THR
232
A
O
ILE
214
A
O
ILE
215
A
O
GLY
213
A
O
GLY
214
A
N
LEU
201
A
N
LEU
202
1
A
LYS
53
-14.40
1
A
A
SER
VAL
25
26
-149.41
1
A
A
PRO
GLN
186
187
-129.31
1
A
TYR
56
0.081
SIDE CHAIN
1
3.93
0.50
120.30
124.23
A
A
A
NE
CZ
NH1
ARG
ARG
ARG
21
21
21
N
1
-3.80
0.50
120.30
116.50
A
A
A
NE
CZ
NH2
ARG
ARG
ARG
21
21
21
N
1
3.09
0.50
120.30
123.39
A
A
A
NE
CZ
NH1
ARG
ARG
ARG
23
23
23
N
1
-3.76
0.50
120.30
116.54
A
A
A
NE
CZ
NH2
ARG
ARG
ARG
23
23
23
N
1
7.48
1.10
114.20
121.68
A
A
A
CA
CB
SG
CYS
CYS
CYS
30
30
30
N
1
-16.25
2.70
111.00
94.75
A
A
A
N
CA
C
SER
SER
SER
36
36
36
N
1
15.27
1.10
114.20
129.47
A
A
A
CA
CB
SG
CYS
CYS
CYS
46
46
46
N
1
16.57
2.20
113.40
129.97
A
A
A
CA
CB
CG
ASP
ASP
ASP
55
55
55
N
1
4.94
0.50
120.30
125.24
A
A
A
NE
CZ
NH1
ARG
ARG
ARG
62
62
62
N
1
-5.87
0.50
120.30
114.43
A
A
A
NE
CZ
NH2
ARG
ARG
ARG
62
62
62
N
1
24.14
2.70
111.20
135.34
A
A
A
CA
CB
OG
SER
SER
SER
63
63
63
N
1
17.38
2.70
111.00
128.38
A
A
A
N
CA
C
GLN
GLN
GLN
70
70
70
N
1
28.77
2.30
115.30
144.07
A
A
A
CA
CB
CG
LEU
LEU
LEU
91
91
91
N
1
-12.16
1.70
111.00
98.84
A
A
A
CB
CG
CD1
LEU
LEU
LEU
91
91
91
N
1
11.24
1.70
111.00
122.24
A
A
A
CB
CG
CD2
LEU
LEU
LEU
91
91
91
N
1
16.60
2.70
111.00
127.60
A
A
A
N
CA
C
ALA
ALA
ALA
92
92
92
N
1
10.29
0.90
118.30
128.59
A
A
A
CB
CG
OD1
ASP
ASP
ASP
96
96
96
N
1
-9.40
0.90
118.30
108.90
A
A
A
CB
CG
OD2
ASP
ASP
ASP
96
96
96
N
1
-11.11
1.80
114.00
102.89
A
A
A
CA
CB
SG
CYS
CYS
CYS
109
109
109
N
1
15.24
2.50
121.70
136.94
A
A
A
C
N
CA
SER
ARG
ARG
113
114
114
Y
1
3.82
0.50
120.30
124.12
A
A
A
NE
CZ
NH1
ARG
ARG
ARG
114
114
114
N
1
-3.47
0.50
120.30
116.83
A
A
A
NE
CZ
NH2
ARG
ARG
ARG
114
114
114
N
1
14.30
2.20
113.40
127.70
A
A
A
CA
CB
CG
ASN
ASN
ASN
143
143
143
N
1
-19.61
2.70
111.00
91.39
A
A
A
N
CA
C
MET
MET
MET
180
180
180
N
1
14.57
2.30
115.30
129.87
A
A
A
CA
CB
CG
LEU
LEU
LEU
181
181
181
N
1
17.90
2.70
111.00
128.90
A
A
A
N
CA
C
GLN
GLN
GLN
187
187
187
N
1
17.64
2.70
111.00
128.64
A
A
A
N
CA
C
LYS
LYS
LYS
189
189
189
N
1
18.71
2.20
113.40
132.11
A
A
A
CA
CB
CG
ASP
ASP
ASP
196
196
196
N
1
-8.08
0.90
118.30
110.22
A
A
A
CB
CG
OD1
ASP
ASP
ASP
196
196
196
N
1
5.25
0.50
120.30
125.55
A
A
A
NE
CZ
NH1
ARG
ARG
ARG
208
208
208
N
1
-5.36
0.50
120.30
114.94
A
A
A
NE
CZ
NH2
ARG
ARG
ARG
208
208
208
N
1
4.30
0.50
120.30
124.60
A
A
A
NE
CZ
NH1
ARG
ARG
ARG
219
219
219
N
1
-4.89
0.50
120.30
115.41
A
A
A
NE
CZ
NH2
ARG
ARG
ARG
219
219
219
N
1
9.63
0.90
118.30
127.93
A
A
A
CB
CG
OD1
ASP
ASP
ASP
225
225
225
N
1
-10.16
0.90
118.30
108.14
A
A
A
CB
CG
OD2
ASP
ASP
ASP
225
225
225
N
1
4.88
0.50
120.30
125.18
A
A
A
NE
CZ
NH1
ARG
ARG
ARG
241
241
241
N
1
-3.96
0.50
120.30
116.34
A
A
A
NE
CZ
NH2
ARG
ARG
ARG
241
241
241
N
1
A
A
CB
OG
SER
SER
33
33
0.087
0.013
1.418
1.505
N
1
A
A
CG
CD
GLU
GLU
78
78
0.091
0.015
1.515
1.606
N
1
A
A
CB
OG
SER
SER
197
197
-0.087
0.013
1.418
1.331
N
1
A
A
NE
CZ
ARG
ARG
241
241
0.086
0.013
1.326
1.412
N
1
A
ARG
23
-64.79
99.35
1
A
SER
25
69.81
-155.49
1
A
VAL
29
-87.42
-70.29
1
A
SER
36
-178.44
147.04
1
A
SER
42
-164.09
-154.81
1
A
GLU
54
-56.98
-9.47
1
A
LEU
65
-25.72
-43.57
1
A
ASN
66
-141.48
38.41
1
A
GLN
70
-51.56
94.51
1
A
LYS
84
-47.95
-6.34
1
A
LEU
91
79.01
-66.19
1
A
ASN
95
39.98
62.18
1
A
ARG
103
177.85
110.28
1
A
CYS
109
-53.96
175.09
1
A
SER
113
-79.62
-137.69
1
A
ILE
116
-152.80
80.64
1
A
TYR
125
23.72
54.19
1
A
CYS
134
-119.27
-166.67
1
A
TYR
171
-93.73
-105.72
1
A
ALA
183
-171.83
144.19
1
A
GLN
187
-31.79
159.85
1
A
TRP
188
81.69
-22.78
1
A
ASP
191
174.81
178.02
1
A
CYS
193
-177.01
-159.61
1
A
GLN
206
72.84
-20.14
1
A
LEU
211
-64.12
73.18
1
A
SER
216
-129.81
-56.72
1
A
ALA
222
76.69
46.97
1
A
LYS
224
-56.58
109.33
1
A
ASP
225
95.54
2.18
11.3
0.00
0.00
0.00
0.00
0.00
0.00
0.248
0.248
3.00
10.00
2625
RANDOM
10000000.00
0.00
1
RESTRAINED
2.0
0.35
5.00
0.27
3.00
10.00
0
1949
16
0
1933
0.026
3.5
28.9
2.35
1.67
1.50
2.48
2.00
2.74
2.00
4.04
2.50
0.251
3.18
460
6
data scaling
SCALEPACK
phasing
AMoRE
refinement
X-PLOR
98.0
UROKINASE (E.C.3.4.21.73)
Crystal structure of human microurokinase in complex with 2-amino-5-hydroxy-benzimidazole
1
N
N
2
N
N
3
N
N
A
THR
8
A
THR
8
HELX_P
A
GLN
12
A
GLN
12
5
1
5
A
ALA
43
A
ALA
44
HELX_P
A
PHE
47
A
PHE
48
5
2
5
A
LYS
52
A
LYS
53
HELX_P
A
GLU
54
A
GLU
55
5
3
3
A
SER
162
A
SER
163
HELX_P
A
GLN
167
A
GLN
168
1
4
6
A
TYR
172
A
TYR
173
HELX_P
A
VAL
176
A
VAL
177
5
5
5
A
PHE
236
A
PHE
237
HELX_P
A
SER
242
A
SER
243
1
6
7
disulf
1.954
A
CYS
30
A
SG
CYS
31
1_555
A
CYS
46
A
SG
CYS
47
1_555
disulf
2.006
A
CYS
38
A
SG
CYS
39
1_555
A
CYS
109
A
SG
CYS
110
1_555
disulf
2.010
A
CYS
134
A
SG
CYS
135
1_555
A
CYS
203
A
SG
CYS
204
1_555
disulf
2.036
A
CYS
166
A
SG
CYS
167
1_555
A
CYS
182
A
SG
CYS
183
1_555
disulf
2.021
A
CYS
193
A
SG
CYS
194
1_555
A
CYS
221
A
SG
CYS
222
1_555
BLOOD CLOTTING
Plasminogen activation, BLOOD CLOTTING
UROK_HUMAN
UNP
1
179
P00749
IIGGEFTTIENQPWFAAIYRRHRGGSVTYVCGGSLMSPCWVISATHCFIDYPKKEDYIVYLGRSRLNSNTQGEMKFEVEN
LILHKDYSADTLAHHNDIALLKIRSKEGRCAQPSRTIQTICLPSMYNDPQFGTSCEITGFGKENSTDYLYPEQLKMTVVK
LISHRECQQPHYYGSEVTTKMLCAADPQWKTDSCQGDSGGPLVCSLQGRMTLTGIVSWGRGCALKDKPGVYTRVSHFLPW
IRSHT
179
423
1FV9
1
244
P00749
A
1
1
245
1
CYS
CONFLICT
ALA
120
1FV9
A
P00749
UNP
299
121
3
7
2
4
anti-parallel
anti-parallel
anti-parallel
anti-parallel
anti-parallel
anti-parallel
anti-parallel
anti-parallel
anti-parallel
anti-parallel
anti-parallel
anti-parallel
A
GLU
5
A
GLU
5
A
PHE
6
A
PHE
6
A
LYS
154
A
LYS
155
A
LYS
159
A
LYS
160
A
SER
133
A
SER
134
A
GLY
138
A
GLY
139
A
SER
25
A
SER
26
A
CYS
30
A
CYS
31
A
ALA
17
A
ALA
17
A
HIS
22
A
HIS
22
A
TYR
56
A
TYR
57
A
LEU
60
A
LEU
61
A
MET
73
A
MET
74
A
LEU
82
A
LEU
83
A
ALA
98
A
ALA
99
A
ARG
103
A
ARG
104
A
TRP
39
A
TRP
40
A
SER
42
A
SER
43
A
SER
33
A
SER
34
A
SER
36
A
SER
37
A
SER
87
A
SER
88
A
ALA
88
A
ALA
89
A
HIS
93
A
HIS
94
A
HIS
94
A
HIS
95
A
MET
180
A
MET
181
A
ALA
183
A
ALA
184
A
LYS
226
A
LYS
227
A
ARG
232
A
ARG
233
A
ARG
208
A
ARG
209
A
LEU
223
A
LEU
224
A
PRO
200
A
PRO
201
A
LEU
205
A
LEU
206
BINDING SITE FOR RESIDUE SO4 A 245
Software
5
BINDING SITE FOR RESIDUE 172 A 246
Software
9
A
HIS
45
A
HIS
46
5
1_555
A
GLN
194
A
GLN
195
5
1_555
A
GLY
195
A
GLY
196
5
1_555
A
SER
197
A
SER
198
5
1_555
A
172
246
C
172
5
1_555
A
ASP
191
A
ASP
192
9
1_555
A
SER
192
A
SER
193
9
1_555
A
CYS
193
A
CYS
194
9
1_555
A
GLN
194
A
GLN
195
9
1_555
A
VAL
215
A
VAL
216
9
1_555
A
GLY
218
A
GLY
219
9
1_555
A
GLY
220
A
GLY
221
9
1_555
A
GLY
228
A
GLY
229
9
1_555
A
SO4
245
B
SO4
9
1_555
19
P 21 21 21